Your session is about to expire
← Back to Search
eXciteOSA for Obstructive Sleep Apnea (OREM Trial)
OREM Trial Summary
This trial is testing a new device to help people with mild sleep apnea. It is open-label, meaning that both the patients and doctors will know which treatment the patients are receiving. Up to 200 people will be enrolled and randomly assigned to either the treatment or no-treatment group.
- Obstructive Sleep Apnea
OREM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.OREM Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many medical facilities are currently engaged in this research endeavor?
"This research project is currently recruiting at 7 different medical sites, such as Pulmonary and Critical Care Associates of Baltimore in Baltimore, Clayton Sleep Institute in Saint Louis, and Florida Lung & Sleep Associates in Lehigh Acres."
Are there any remaining vacancies for this clinical experiment?
"From the data posted on clinicaltrials.gov, it appears that recruitment for this medical trial has already concluded; first being listed on January 17th 2022 before its last update in December 1st of the same year. However, there are more than two hundred and eighty-nine other studies looking to enrol participants at this time."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger